Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Finnamore, Helen ^a,c,d   Le Couteur, James ^b   Hickson, Mary ^b   Busbridge, Mark ^b   Whelan, Kevin ^c   Shovlin, Claire L ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; FERRITIN; FERROUS FUMARATE; FERROUS GLUCONATE; FERROUS SULFATE; HEMOGLOBIN; HEPCIDIN; IRON;

ADULT; AGED; ANEMIA; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFECT; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISTAXIS; ERYTHROCYTE COUNT; FEMALE; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGE ADJUSTED IRON REQUIREMENT; HEMORRHAGIC IRON DEFICIENCY; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON INTAKE; IRON THERAPY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MENSTRUATION; NAUSEA; PREDICTION; PREMENOPAUSE; RENDU OSLER WEBER DISEASE;

ADULT; AGED; DIET; DIETARY SUPPLEMENTS; EPISTAXIS; FEMALE; HEMATINICS; HEPCIDINS; HUMANS; IRON; IRON, DIETARY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; RECOMMENDED DIETARY ALLOWANCES; REGRESSION ANALYSIS; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 84885738700     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076516     Document Type: Article

References (65)

1. McLean E, Cogswell M, Egli I, Wojdyla D, Benoist B, (2009) Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 12: 444-54.
2. Center for Disease Control (2002) Iron Deficiency United States, 1999-2000. MMWR Weekly 51: 897-899. Available: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5140a1.htm#tab1. Accessed 2013 Sep 9.
3. World Health Organization (2002) The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva 2002. Available: http://www.who.int/whr/2002/en/whr02_en.pdf. Accessed 2013 Sep 9.
4. Ganz T, (2011) Hepcidin and iron regulation, 10 years later. Blood 117: 4425-33.
5. Shaw STJ, Aaronson DE, Moyer DL, (1972) Quantitation of menstrual blood loss-further evaluation of the alkaline hematin method. Contraception 5: 497-513.
6. Hallberg L, Högdahl A-M, Nilsson L, Rybo G, (1966) Menstrual blood loss and iron deficiency. Acta Medica Scandinavica 180: 639-50.
7. Nelson M, Erens B, Bates B, Church S, Boshier T, editors (2007) Low income diet and nutrition survey - Food Standards Agency. London: The Stationary Office.
8. Thane C, Bates C, Prentice A, (2003) Risk factors for low iron intake and poor iron status in a national sample of British young people aged 4-18 years. Public Health Nutr 6: 485-96.
9. Goddard AF, James MW, McIntyre AS, Scott BB, (2011) British Society of Gastroenterology (2011) Guidelines for the management of iron deficiency anaemia. Gut 60: 1309-1316.
10. United Nations Children's Fund, United Nations University and World Health Organization (2001) Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers. WHO/NHD/01.3 Geneva.
11. Centers for Disease Control and Prevention (1998) Recommendations to prevent and control iron deficiency in the United States. MMWR Recomm Rep 47: 1e36.
12. Anand IS, Chandrashekhar Y, Wander GS, Chawla LS, (1995) Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia. J Am Coll Cardiol 25: 1402-7.
13. Smith TG, Balanos GM, Croft QP, Talbot NP, Dorrington KL, et al. (2008) The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. J Physiol 586: 5999-6005.
14. Livesey JA, Manning R, Meek JH, Jackson JE, Kulinskaya E, et al. (2012) Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli/deep venous thromboses in replicate cohorts of patients with hereditary hemorrhagic telangiectasia. Thorax 67: 328-33.
15. Guttmacher AE, Marchuk DA, White RI, (1995) Hereditary hemorrhagic telangiectasia. New Engl J Med 333: 918-924.
16. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, et al. (2011) International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 48: 73-87.
17. Shovlin CL, (2010) Hereditary hemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 24: 203-19.
18. Buscarini E, Leandro G, Conte D, Danesino C, Daina E, et al. (2011) Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic telangiectasia. Dig Dis Sci 56: 2166-78.
19. Whyte MK, Hughes JM, Jackson JE, Peters AM, Hempleman SC, et al. (1993) Cardiopulmonary response to exercise in patients with intrapulmonary vascular shunts. J Appl Physiol 75: 321-328.
20. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, et al. (2003) Hemodilution is common in patients with advanced heart failure. Circulation 107: 226-9.
21. Zeidman A, Fradin Z, Blecher A, Oster HS, Avrahami Y, et al. (2004) Anemia as a risk factor for ischemic heart disease. Isr Med Assoc J 6: 16-8.
22. Alleyne M, Horne MK, Miller JL, (2008) Individualized treatment for iron-deficiency anemia in adults. Am J Med 121: 943-8.
23. Spielmann M, Luporsi E, Ray-Coquard I, de Botton S, Azria D, et al. (2012) Diagnosis and management of anemia and iron deficiency in patients with hematological malignancies or solid tumours in France in 2009-2010: the AnemOnHe study. Eur J Cancer 48: 101-7.
24. Goodnough LT, Maniatis A, Earnshaw P, Benoni G, Beris P, et al. (2011) Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 106: 13-22.
25. Milman N, (2012) Postpartum anemia II: prevention and treatment. Ann Hematol 91: 143-54.
26. Royal Pharmaceutical Society of Great Britain and British Medical Association (2012) British National Formulary 63: BMJ Publishing Group, London.
27. Hallberg L, Ryttinger L, Solvell L (1966) Side-effects of oral iron therapy. A double-blind study of different iron compounds in tablet form. Acta Med Scand Suppl 459: 3-10.
28. Centers for Disease Control and Prevention (2011). Nutrition for everyone: Basics: Iron and iron deficiency. Available: http://www.cdc.gov/nutrition/everyone/basics/vitamins/iron.html. Accessed 2013 Sep 9.
29. Pasricha SR, (2012) Should we screen for iron deficiency anaemia? A review of the evidence and recent recommendations. Pathology 44(2): 139-47.
30. Valberg LS, (1980) Plasma ferritin concentrations: their clinical significance and relevance to patient care. Can Med Assoc J 122: 1240-8.
31. NICE Clinical Knowledge Summaries: Interpreting ferritin levels. Available: http://cks.nhs.uk/anaemia_iron_deficiency/management/scenario_diagnosis/investigations/interpreting_ferritin_levels#. Accessed 2013 Sep 9.
32. Roked F, Jackson JE, Fuld J, Basheer FT, Chilvers ER, et al. (2011) Pulmonary thromboemboli modifying the natural history of pulmonary arteriovenous malformations. Am J Resp Crit Care Med 183: 828-9.
33. Santhirapala V, Howard LSGE, Murphy K, Mukherjee B, Busbridge M, et al. (2013) Oxygen delivery and consumption is preserved in hypoxaemic patients with pulmonary arteriovenous malformations and hereditary haemorrhagic telangiectasia. Hematology Reports 5 (s1) 33-34.
34. Boulton F, (2008) Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med 18: 13-27.
35. Abdullah SM, (2011) The effect of repeated blood donations on the iron status of male Saudi blood donors. Blood Transfus 9: 167-71.
36. Hallberg L, (2000) New tools in studies on iron nutrition. Principles, applications and consequences. Scand J Nutr 44: 150-154.
37. Silva BM, Hosman AE, Devlin HL, Shovlin CL (2013) A questionnaire-based study suggests lifestyle and dietary factors influencing nosebleed severity in hereditary hemorrhagic telangiectasia (HHT). Laryngoscope, 2013 doi: 10.1002/lary.23893.
38. Pope LER, Hobbs CGL, (2005) Epistaxis: an update on current management. Postgrad Med J. 81: 309-14.
39. Tay HL, Evans JM, McMahon AD, MacDonald TM, (1998) Aspirin, nonsteroidal anti-inflammatory drugs, and epistaxis. A regional record linkage case control study. Ann Otol Rhinol Laryngol 107: 671-4.
40. Saban Y, Amodeo CA, Bouaziz D, Polselli R, (2012) Nasal Arterial Vasculature Arch Facial Plast Surg. 14: 429-36.
41. Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, et al. (2011) Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol 58: 300e9.
42. Girerd B, Montani D, Coulet F, et al. (2010) Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 2010 181: 851-61.
43. Frykman E, Bystrom M, Jansson U, Edberg A, Hansen T, (1994) Side effects of iron supplements in blood donors: superior tolerance of heme iron. J Lab Clin Med 123: 561-4.
44. Royal Pharmaceutical Society of Great Britain and British Medical Association (2012) British National Formulary 63: BMJ Publishing Group, London.
45. Rimon E, Kagansky N, Kagansky M, Mechnick L, Mashiah T, et al. (2005) Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 118: 1142-7.
46. Hallberg L, (2001) Perspectives on nutritional iron deficiency. Ann Rev Nutrition 21: 1-21.
47. Aronstam A, Aston DL, (1982) A comparative trial of a controlled-release iron tablet preparation ('Ferrocontin' Continus) and ferrous fumarate tablets. Pharmatherapeutica 3: 263-7.
48. National Institute for Health and Clinical Excellence (NICE) (2011) Colorectal cancer. Costing report. Implementing NICE Guidance. Available: http://guidance.nice.org.uk/CG131/CostingReport/pdf/English. Accessed 2013 Sep 9.
49. Curtis L (2011). Unit costs of health and social care 2011. PSSRU, Canterbury. Available: http://www.pssru.ac.uk/uc/uc2011contents.htm. Accessed 2013 September 9.
50. Hoag J, Terry P, Mitchell S, Reh D, Merlo C, (2010) An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 120: 838-43.
51. Burdett E, Stephens R, (2006) Blood transfusion: a practical guide. Br J Hosp Med (Lond) 67: 200-5.
52. Royal College of Obstetricians and Gynaecologists (2009) Prevention and management of postpartum hemorrhage. Green-top Guideline no 52. Available: http://www.rcog.org.uk/womens-health/clinical-guidance/prevention-and-management-postpartum-haemorrhage-green-top-52. Accessed 2013 Sep 9.
53. Swain DG, Nightingale PG, Patel JV, (2000) Transfusion requirements in femoral neck fracture. Injury 31: 7-10.
54. Shovlin CL, Guttmacher AE, Buscarini E, Faughan M, Hyland R, et al. (2000) Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 91: 66-7.
55. International Agency for Research on Cancer and World Health Organisation (2010) European Prospective Investigation into Cancer and Nutrition. British Medical Association. Available: http://epic.iarc.fr/about.php. Accessed 2013 September 9.
56. Welch AA, Luben R, Khaw KT, Bingham SA, (2005) The CAFE computer program for nutritional analysis of the EPIC-Norfolk food frequency questionnaire and identification of extreme nutrient values. J Hum Nutr Dietet 18: 99-116.
57. Bingham SA, Welch AA, McTaggart A, Mulligan AA, Runswick SA, et al. (2001) Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr 4: 847-58.
58. Busbridge M, Griffiths C, Ashby D, Gale D, Jayantha A, et al. (2009) Development of a novel immunoassay for the iron regulatory peptide hepcidin. Br J Biomed Sci 66: 150-7.
59. Devlin HL, Hosman AE, Shovlin CL, (2013) Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia. N Engl J Med 368: 876-8.
60. (2004) The National Diet & Nutrition Survey: Adults aged 19 to 64 years. Nutritional status (anthropometry and blood analytes), blood pressure and physical activity. HMSO, Norwich. Available: http://www.food.gov.uk/multimedia/pdfs/ndnsfour.pdf. Page 63, table 4.1. Accessed 2013 Sep 9.
61. Franzini CBA, Favarelli C, Brambilla S, (2000) Low frequency of elevated serum transferrin saturation in elderly subjects. Clin Chim Acta 298: 181-6.
62. Tan TC, Crawford DH, Franklin ME, Jaskowski LA, Macdonald GA, et al. (2012) The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver Int 32: 1391-9.
63. Piperno A, Girelli D, Nemeth E, Trombini P, Bozzini C, et al. (2007) Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood 110: 4096-4100.
64. Department of Health (1991) Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. HMSO, London.
65. Kerr DN, Davidson S, (1958) Gastrointestinal intolerance to oral iron preparations. Lancet 2: 489-92.